Assay Kits_abinScience

RBD (E484K) (1)

Epcoritamab (1)

gE/Envelope glycoprotein E (1)

Bimekizumab (1)

Figitumumab (1)

Tarextumab (1)

Simlukafusp Alfa (1)

Milatuzumab (1)

Meplazumab (1)

Rituximab (1)

Adalimumab (3)

Oleclumab (1)

Obiltoxaximab (1)

Benufutamab (1)

Crizanlizumab (1)

EPO/Erythropoietin (1)

Blosozumab (1)

Romosozumab (1)

RBD (Kappa) (1)

Glofitamab (1)

gD/Envelope glycoprotein D (1)

Ixekizumab (1)

Ganitumab (1)

Urelumab (1)

IL6 (1)

Disitamab (1)

Alacizumab (1)

Natalizumab (2)

Certolizumab (2)

Zampilimab (1)

Gremubamab (1)

Conatumumab (1)

Inclacumab (1)

Olaratumab (1)

Mirikizumab (2)

RBD (Delta Plus) (1)

Ibritumomab (1)

gC/Envelope glycoprotein C (1)

Remtolumab (1)

Teprotumumab (1)

Utomilumab (1)

Aflibercept (1)

Pertuzumab (3)

Ramucirumab (1)

Romiplostim (2)

Golimumab (2)

Vofatamab (1)

M1R (5)

Drozitumab (1)

Tovetumab (1)

Dilpacimab (1)

RBD (Delta) (3)

Mosunetuzumab (1)

gC/UL44 (1)

Secukinumab (2)

Apamistamab (1)

Magrolimab (1)

sCD14 (1)

Trastuzumab (2)

Ascrinvacumab (1)

Sotrovimab (1)

Infliximab (2)

Oxelumab (1)

H3L (3)

Lexatumumab (1)

E8L (5)

Tigatuzumab (1)

Ipilimumab (2)

Navicixizumab (1)

A29L (6)

Ocaratuzumab (1)

gD/US6 (1)

Tibulizumab (1)

Emibetuzumab (1)

Sibrotuzumab (1)

Zanidatamab (1)

Cinpanemab (1)

Casirivimab (1)

Canakinumab (1)

Dupilumab (3)

A35R (5)

Faricimab (1)

Tremelimumab (1)

Atezolizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Carlumab (1)

US8/gE (1)

Vunakizumab (1)

Tocilizumab (3)

Amatuximab (1)

Zenocutuzumab (1)

CD79B (2)

Imdevimab (1)

Gevokizumab (1)

Iscalimab (1)

Varlilumab (1)

Eculizumab (3)

Nesvacumab (1)

Zalifrelimab (1)

Avelumab (3)

NP/Nucleoprotein (3)

Lorvotuzumab (1)

Spike glycoprotein E2 (2)

Tiragolumab (2)

Lacnotuzumab (1)

Anetumab (1)

Clazakizumab (1)

Ivuxolimab (1)

F/Fusion glycoprotein F0 (5)

Basiliximab (1)

Camidanlumab (1)

Talacotuzumab (1)

Denosumab (3)

Vanucizumab (1)

Edrecolomab (1)

Durvalumab (3)

IL1RL1/ST2 (1)

Tisotumab (1)

Spike glycoprotein E1 (2)

Enoblituzumab (1)

Sacituzumab (1)

RBD (Omicron/BA.4/BA.5) (1)

Ontamalimab (1)

Olokizumab (1)

Pogalizumab (1)

Guselkumab (2)

Elotuzumab (1)

Daclizumab (1)

Vibecotamab (1)

Cetuximab (3)

Lupartumab (1)

Rolinsatamab (1)

Pacmilimab (1)

cAMP (1)

Imalumab (1)

dsRNA (1)

Mirzotamab (1)

Semorinemab (1)

Semaglutide (1)

Glembatumumab (1)

Sirukumab (1)

Tavolimab (1)

Lirilumab (1)

Evolocumab (1)

Ibalizumab (1)

Bimagrumab (1)

Sarilumab (2)

Depatuxizumab (1)

Anifrolumab (1)

Nirsevimab (1)

cGMP (1)

Andecaliximab (1)

ATP7B (1)

Omburtamab (1)

Tilavonemab (1)

B6R/SL-159 (1)

Balstilimab (1)

Ziltivekimab (1)

Codrituzumab (1)

Alirocumab (1)

Tregalizumab (1)

Daratumumab (3)

Ustekinumab (3)

Losatuxizumab (1)

Icrucumab (1)

Palivizumab (3)

BSA (1)

Farletuzumab (1)

TPP15 (1)

Frovocimab (1)

Nivolumab (5)

Zagotenemab (1)

RBD (Omicron/JN.1) (1)

Cetrelimab (1)

Cergutuzumab (1)

Labetuzumab (1)

Astegolimab (1)

RBD (Omicron/BA.5) (3)

Zanolimumab (1)

Ifabotuzumab (1)

Omalizumab (2)

Necitumumab (1)

Ieramilimab (1)

Suptavumab (1)

Protein A (1)

Mirvetuximab (1)

TPP17 (1)

Lodelcizumab (1)

Etanercept (3)

Befovacimab (1)

RBD (Omicron/KP.2) (1)

Pembrolizumab (3)

Cabiralizumab (1)

Belantamab (1)

dsDNA (1)

Eldelumab (1)

Letolizumab (1)

RBD (6)

Panitumumab (3)

Mavezelimab (1)

Suvizumab (1)

Human β Amyloid (1-42) (1)

Bevacizumab (3)

TPP47 (1)

Tezepelumab (1)

RBD (WT) (1)

Concizumab (1)

CD340/ERBB2 (1)

Sintilimab (1)

Tislelizumab (1)

Emactuzumab (1)

Teclistamab (1)

Glycoprotein (5)

Lenzilumab (1)

Itolizumab (1)

Spike glycoprotein (9)

Serclutamab (1)

Favezelimab (1)

Foravirumab (1)

Human β Amyloid (1-40) (1)

Brolucizumab (1)

G/Major surface glycoprotein G (1)

Elezanumab (1)

RBD (Alpha) (1)

Marstacimab (1)

M/Matrix protein (2)

gG/US4 (2)

Toripalimab (1)

Cixutumumab (1)

Pasotuxizumab (1)

GP/Envelope glycoprotein (4)

Namilumab (1)

Cusatuzumab (1)

Spike Protein (Trimer) (2)

Tesidolumab (1)

Indatuximab (1)

Rafivirumab (1)

TAU pT181 (1)

Ranibizumab (3)

N/Nucleoprotein (1)

Enfortumab (1)

RBD (Beta) (1)

Obinutuzumab (2)

Afutuzumab (1)

gB/Envelope glycoprotein B (1)

Afasevikumab (1)

Dalotuzumab (1)

Rosopatamab (2)

Tirzepatide (2)

Otilimab (1)

Vorsetuzumab (1)

NP/Nucleocapsid (5)

Tanezumab (1)

Lintuzumab (1)

Tosatoxumab (1)

TAU pT217 (1)

Varisacumab (1)

Spike glycoprotein (RBD) (1)

Ianalumab (1)

RBD (Gamma) (1)

Recombinant Proteins

Antibodies

Assay Kits

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Sensitivity

Range

Sample type

Range

Sample type

Range

Quick access

Contact us